NewAmsterdam Pharma
NAMS
NAMS
29 hedge funds and large institutions have $581M invested in NewAmsterdam Pharma in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
18.57% more ownership
Funds ownership: 40.89% → 59.45% (+19%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
29
Holding in Top 10
3
Calls
$3.44M
Puts
–
Top Buyers
| 1 | +$59.5M | |
| 2 | +$31M | |
| 3 | +$25.8M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$18.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$14.3M |